Hainfellner JA - Search Results

1

Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.

Preusser M, Charles Janzer R, Felsberg J, Reifenberger G, Hamou MF, Diserens AC, Stupp R, Gorlia T, Marosi C, Heinzl H, Hainfellner JA, Hegi M. Preusser M, et al. Among authors: hainfellner ja. Brain Pathol. 2008 Oct;18(4):520-32. doi: 10.1111/j.1750-3639.2008.00153.x. Epub 2008 Apr 8. Brain Pathol. 2008. PMID: 18400046 Free PMC article.

2

Phenotypic variation in Creutzfeldt-Jakob disease, May 31 and June 1, 1996, Vienna, Austria.

Budka H, Hainfellner JA. Budka H, et al. Among authors: hainfellner ja. Brain Pathol. 1996 Oct;6(4):527-30. doi: 10.1111/j.1750-3639.1996.tb00883.x. Brain Pathol. 1996. PMID: 8944323 No abstract available.

3

Pathology and immunocytochemistry of a kuru brain.

Hainfellner JA, Liberski PP, Guiroy DC, Cervénaková L, Brown P, Gajdusek DC, Budka H. Hainfellner JA, et al. Brain Pathol. 1997 Jan;7(1):547-53. doi: 10.1111/j.1750-3639.1997.tb01072.x. Brain Pathol. 1997. PMID: 9034563 Free PMC article.

4

The Austrian FFI cases.

Budka H, Almer G, Hainfellner JA, Brücke T, Jellinger K. Budka H, et al. Among authors: hainfellner ja. Brain Pathol. 1998 Jul;8(3):554. doi: 10.1111/j.1750-3639.1998.tb00179.x. Brain Pathol. 1998. PMID: 9669708 Free PMC article. No abstract available.

5

No complementation between TP53 or RB-1 and v-src in astrocytomas of GFAP-v-src transgenic mice.

Maddalena AS, Hainfellner JA, Hegi ME, Glatzel M, Aguzzi A. Maddalena AS, et al. Among authors: hainfellner ja. Brain Pathol. 1999 Oct;9(4):627-37. doi: 10.1111/j.1750-3639.1999.tb00544.x. Brain Pathol. 1999. PMID: 10517501 Free PMC article.

6

Evidence of therapeutic efficacy of CCNU in recurrent choroid plexus papilloma.

Valencak J, Dietrich W, Raderer M, Dieckmann K, Prayer D, Hainfellner JA, Marosi C. Valencak J, et al. Among authors: hainfellner ja. J Neurooncol. 2000 Sep;49(3):263-8. doi: 10.1023/a:1006405106553. J Neurooncol. 2000. PMID: 11212906 Review.

7

Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes.

Kovács GG, Head MW, Hegyi I, Bunn TJ, Flicker H, Hainfellner JA, McCardle L, László L, Jarius C, Ironside JW, Budka H. Kovács GG, et al. Among authors: hainfellner ja. Brain Pathol. 2002 Jan;12(1):1-11. doi: 10.1111/j.1750-3639.2002.tb00417.x. Brain Pathol. 2002. PMID: 11770893 Free PMC article.

8

Prognostic relevance of p53 protein expression in glioblastoma.

Birner P, Piribauer M, Fischer I, Gatterbauer B, Marosi C, Ungersböck K, Rössler K, Budka H, Hainfellner JA. Birner P, et al. Among authors: hainfellner ja. Oncol Rep. 2002 Jul-Aug;9(4):703-7. Oncol Rep. 2002. PMID: 12066196

9

High expression of DNA topoisomerase IIalpha and Ki-67 antigen is associated with prolonged survival in glioblastoma patients.

Bredel M, Piribauer M, Marosi C, Birner P, Gatterbauer B, Fischer I, Ströbel T, Rössler K, Budka H, Hainfellner JA. Bredel M, et al. Among authors: hainfellner ja. Eur J Cancer. 2002 Jul;38(10):1343-7. doi: 10.1016/s0959-8049(02)00065-5. Eur J Cancer. 2002. PMID: 12091064

10

Feasibility and toxicity of CCNU therapy in elderly patients with glioblastoma multiforme.

Piribauer M, Fazeny-Dörner B, Rössler K, Ungersböck K, Czech T, Killer M, Dieckmann K, Birner P, Prayer D, Hainfellner J, Muhm M, Marosi C. Piribauer M, et al. Anticancer Drugs. 2003 Feb;14(2):137-43. doi: 10.1097/00001813-200302000-00007. Anticancer Drugs. 2003. PMID: 12569300 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

328 results

Search Page